There is growing evidence that the appearance and texture of the skin that is altered during the aging process are considerably enhanced by the accumulation of senescent dermal fibroblasts. These senescent cells magnify aging ...
Oct 31, 2022
0
3
A big group of bacteria found in our soil, our water and our showerheads are harmless for most of us, but a new study indicates they are associated with an increased risk of dying in individuals whose kidneys have failed.
Oct 25, 2022
0
7
The severity of children's atopic dermatitis (AD) in first grade may predict its persistence in sixth grade, according to a study published online Sept. 19 in the Journal of Dermatology.
Oct 24, 2022
0
4
The skin is a large, complex organ, and it serves as the body's primary interface with the environment, playing key roles in sensory, thermoregulatory, barrier, and immunological functioning.
Oct 20, 2022
0
1
Florida residents dealing with the horrific aftermath of Hurricane Ian now need to be concerned about a spike in flesh-eating bacteria cases, health officials warned.
Oct 18, 2022
0
29
Organ damage occurs in up to 70% of patients in the first few months following stem cell transplant. The precise reasons for this potentially life-threatening reaction have long been the subject of scientific research.
Oct 13, 2022
0
40
A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC). The trial will evaluate the drug's safety and ...
Oct 13, 2022
0
7
Thirdhand smoke, or THS, comprises the residual pollutants from tobacco smoke that remain on surfaces and in dust after tobacco has been smoked. It can remain on indoor surfaces indefinitely, causing potentially harmful exposure ...
Oct 11, 2022
0
99
Systemic sclerosis—or scleroderma that affects the skin and internal organs—is one of the rarest autoimmune diseases, affecting roughly 100,000 people (primarily women) in the United States. However, systemic sclerosis ...
Oct 6, 2022
0
14
The U.S. Food and Drug Administration approved Dupixent (dupilumab) as the first treatment for adults with prurigo nodularis, according to Regeneron Pharmaceuticals.
Oct 3, 2022
0
4
